When it comes to clinical quality measures, “exclusions” are a surprisingly tricky concept. The basic idea is simple - some patients should be excluded from a quality measure. Think adult weight screening measure and pregnant patients or the breast...
Chronic disease. This is one of the biggest health challenges the United States faces as a nation. Despite some pockets of success in population health designed to manage chronic disease, as a country and as a system, we are failing. Compared to our...
Hello from Boston! I can hardly believe we are entering March and will soon be headed to the NACHC P&I Conference in Washington DC. As we exit UDS season, I wanted to take a moment to reflects on my observations.
We deal with a lot of data here at Azara. I mean a lot of data. We gather information from hundreds of unique sources and collate this data into the numerous reports and measures that our customers use in the DRVS application. In a perfect world,...
Addiction, the opioid epidemic, overdose, are words seen and heard daily across various news venues and often in a negative context. It’s a complex problem – driven by the legal and illegal drug trade that gave rise to the current epidemic. If you...
As 2017 comes to a close, I wanted to take a moment to reflect on the past year. Wow, what a year it has been! From a geographical standpoint, the Azara team has visited DRVS users, prospects and partners across 36 states. Our team is not just...
